Skip to main content
Category

News Archive

partnership-nyc-medcity

12 Industry-Venture Fund Alliances: 2014 Edition – GEN

By News Archive

partnership-nyc-medcityIt helps to have a friend. And for several pharma giants scrambling to cut R&D costs, those friends are venture capital firms that co-invest in startups whose new drugs and platform technologies appear attractive. In some cases, these pharma-venture “alliances” launch the startups, using the expertise of VC firm partners and company executives.

Read More
johns-hopkins-jhu-logo

New Lab Keeps Md. On Cutting Edge Of Health & Technology – CBS Baltimore

By News Archive

johns-hopkins-jhu-logoInfectious diseases, pathogens and bioterrorism agents are all inside a new building downtown. Jessica Kartalija explains it’s great news for researchers at Johns Hopkins. It’s the newest addition to the Baltimore Science and Technology Park at Johns Hopkins. Inside, it’s a state-of-the-art lab that will keep Maryland on the cutting edge of public health and technology.

Read More
Foundersfundlogo

Founders Fund will give dough to early-stage science startups – VentureBeat

By News Archive

FoundersfundlogoFounders Fund already stands out for backing startups with radical ideas, including Counsyl, Hampton Creek, Planet Labs, and SpaceX. Now the venture firm is making a formal commitment to funding startups in aeronautics, life sciences, nanotechnology, and other geeky realms. Founders Fund has dedicated a small percentage of its new $1 billion fund to a new initiative called FF Science, through which the firm will make seed-stage deals.

Read More
lupin-logo

Lupin, Other U.S. Firms Consider Bid For GSK Generics – Pharmaceutical Online

By News Archive

lupin-logoInside sources reveal that Indian pharmaceutical generics firm Lupin, along with other U.S. pharma firms, is considering bidding for GlaxoSmithKline’s auctioned mature and generic drugs.

GSK seeks to divest its lineup of mature drugs in an effort to improve its growth profile by getting rid of its off-patent drugs in North America and Western Europe. The drugs are estimated to bring in annual sales of 1 billion pounds and are expected to fetch two to three times the price on the auction block.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.